124 related articles for article (PubMed ID: 29279067)
1. [Breast Cancer: Value-Based Healthcare, Costs and Financing].
Harfouche A; Silva S; Faria J; Araújo R; Gouveia A; Lacerda M; D'Orey L
Acta Med Port; 2017 Nov; 30(11):762-768. PubMed ID: 29279067
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast cancer: we do need primary cost data.
Bonastre J; Jan P; Barthe Y; Koscielny S
Breast; 2012 Jun; 21(3):384-8. PubMed ID: 22520336
[TBL] [Abstract][Full Text] [Related]
3. [Cost-effectiveness of trastuzumab in the treatment of early stages breast cancer patients, in Portugal].
Macedo A; Monteiro I; Andrade S; Cirrincione A; Ray J
Acta Med Port; 2010; 23(3):475-82. PubMed ID: 20654267
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a short stay admission programme for breast cancer surgery.
de Kok M; Dirksen CD; Kessels AG; van der Weijden T; van de Velde CJ; Roukema JA; Bell AV; van der Ent FW; von Meyenfeldt MF
Acta Oncol; 2010 Apr; 49(3):338-46. PubMed ID: 20397768
[TBL] [Abstract][Full Text] [Related]
5. Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer.
Jacobs VR; Mayer SC; Paessens BJ; Bernard R; Harbeck N; Kiechle M; Ihbe-Heffinger A
Onkologie; 2011; 34(11):614-8. PubMed ID: 22104158
[TBL] [Abstract][Full Text] [Related]
6. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
[TBL] [Abstract][Full Text] [Related]
7. [Cost of breast cancer treatment by clinical stage in the Basque Country, Spain].
Arrospide A; Soto-Gordoa M; Acaiturri T; López-Vivanco G; Abecia LC; Mar J
Rev Esp Salud Publica; 2015; 89(1):93-7. PubMed ID: 25946589
[TBL] [Abstract][Full Text] [Related]
8. [Estimating the microcosts of blood transfusion for hemato-oncological patients].
Brilhante D; Macedo A; Santos A
Acta Med Port; 2008; 21(6):575-80. PubMed ID: 19331791
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.
Aarts MJ; Grutters JP; Peters FP; Mandigers CM; Dercksen MW; Stouthard JM; Nortier HJ; van Laarhoven HW; van Warmerdam LJ; van de Wouw AJ; Jacobs EM; Mattijssen V; van der Rijt CC; Smilde TJ; van der Velden AW; Temizkan M; Batman E; Muller EW; van Gastel SM; Joore MA; Borm GF; Tjan-Heijnen VC
J Clin Oncol; 2013 Dec; 31(34):4283-9. PubMed ID: 24166522
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer.
Frederix GW; Severens JL; Hövels AM; van Hasselt JG; Raaijmakers JA; Schellens JH
Breast Cancer Res Treat; 2013 Jun; 139(2):489-95. PubMed ID: 23645005
[TBL] [Abstract][Full Text] [Related]
11. Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.
de Kok M; Frotscher CN; van der Weijden T; Kessels AG; Dirksen CD; van de Velde CJ; Roukema JA; Bell AV; van der Ent FW; von Meyenfeldt MF
BMC Cancer; 2007 Jul; 7():117. PubMed ID: 17605796
[TBL] [Abstract][Full Text] [Related]
12. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing.
Wilkinson AN; Seely JM; Rushton M; Williams P; Cordeiro E; Allard-Coutu A; Look Hong NJ; Moideen N; Robinson J; Renaud J; Mainprize JG; Yaffe MJ
Curr Oncol; 2023 Aug; 30(9):7860-7873. PubMed ID: 37754486
[TBL] [Abstract][Full Text] [Related]
13. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
14. Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria.
Gruber R; Walter E; Helbich TH
Eur J Radiol; 2010 Jun; 74(3):519-24. PubMed ID: 19427153
[TBL] [Abstract][Full Text] [Related]
15. Cost-Efficiency of Breast Cancer Care in the US Military Health System: An Economic Evaluation in Direct and Purchased Care.
Eaglehouse YL; Georg MW; Richard P; Shriver CD; Zhu K
Mil Med; 2019 Oct; 184(9-10):e494-e501. PubMed ID: 30839064
[TBL] [Abstract][Full Text] [Related]
16. [Variability and opportunity costs among the surgical alternatives for breast cancer].
Angulo-Pueyo E; Ridao-López M; Martínez-Lizaga N; García-Armesto S; Bernal-Delgado E
Gac Sanit; 2014; 28(3):209-14. PubMed ID: 24491512
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.
Schrauder MG; Brunel-Geuder L; Häberle L; Wunderle M; Hoyer J; Reis A; Schulz-Wendtland R; Beckmann MW; Lux MP
Breast; 2017 Apr; 32():186-191. PubMed ID: 28214786
[TBL] [Abstract][Full Text] [Related]
18. Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.
Pascarella G; Capasso A; Nardone A; Triassi M; Pignata S; Arenare L; Ascierto P; Curvietto M; Maiolino P; D'Aniello R; Montanino A; Laudato F; De Feo G; Botti G; Perrone F; Petrillo A; Cavalcanti E; Lastoria S; Maurea N; Morabito A
PLoS One; 2019; 14(1):e0210330. PubMed ID: 30620767
[TBL] [Abstract][Full Text] [Related]
19. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
20. Time-Driven Activity-Based Costing: A Comparative Cost Analysis of Whole-Breast Radiotherapy Versus Balloon-Based Brachytherapy in the Management of Early-Stage Breast Cancer.
Schutzer ME; Arthur DW; Anscher MS
J Oncol Pract; 2016 May; 12(5):e584-93. PubMed ID: 27006360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
